SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023249
Filing Date
2022-11-08
Accepted
2022-11-08 16:19:52
Documents
48
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20220930.htm   iXBRL 10-Q 2841383
2 EX-31.1 alec-ex31_1.htm EX-31.1 30398
3 EX-31.2 alec-ex31_2.htm EX-31.2 30392
4 EX-32.1 alec-ex32_1.htm EX-32.1 11606
5 EX-32.2 alec-ex32_2.htm EX-32.2 11647
  Complete submission text file 0000950170-22-023249.txt   7148002

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20220930_lab.xml EX-101.LAB 307525
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20220930.xsd EX-101.SCH 30154
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20220930_pre.xml EX-101.PRE 212518
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alec-20220930_def.xml EX-101.DEF 116960
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alec-20220930_cal.xml EX-101.CAL 34011
42 EXTRACTED XBRL INSTANCE DOCUMENT alec-20220930_htm.xml XML 1092178
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 221369198
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences